Protective effect of melatonine against radiation induced nephrotoxicity in rats

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 4101-4105

  Kucuktulu, Eda ^a  

^a Trabzon Kanuni Training and Research Hospital   (Turkey)

Author keywords

Melatonine; Nephrotoxicity; Radiotherapy; Rat model

Indexed keywords

ANTIOXIDANT; MELATONIN; RADIOPROTECTIVE AGENT;

ANIMAL; ARTICLE; GAMMA RADIATION; KIDNEY FAILURE; MALE; NEPHROSCLEROSIS; RADIATION INJURY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIOXIDANTS; GAMMA RAYS; MALE; MELATONIN; NEPHROSCLEROSIS; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RENAL INSUFFICIENCY;

EID: 84873666588     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.4101     Document Type: Article

References (48)

1. Andreassen CN, Grau C, Lindegoard JC (2003). Chemical radioprotection: a critical review of amifostine as a cytoprotector in radiotherapy. Seminars in Radiation Oncology, 13, 62-72.
2. Blask DE, Sauer LA, Dauchy RT (2002). Melatonin as a chronobiotic/anticancer agent: cellular, biochemical and molecular mechanisms of action and their implications for circadian-based cancer therapy. Current Topics in Medicinal Chemistry, 2, 113-32.
3. Blickenstaff RT, Brandstadter SM, Reedy S (1994). Potential radioprotective agents: 1. homologs of melatonin. J Pharm Sci, 83, 216-8.
4. Bohle A, Mackensen-Haen S, Gise H (1990). The consequences of tubulo-interstitial changes for renal function in glomerulopathies. Pathol Res Pract, 186, 135-44.
5. Bornman MS, Oosthuizen JMC, Barnard HC (1989). Melatonin and sperm motility. Andrologia, 21, 483-5.
6. Brzenzinski A, Seibel MM, Lynch HJ (1987). Melatonin in human preovulatory follicular fluid. J Clin Endocrinol Metab, 64, 865-7.
7. Casado-Zapico S, Rodringuez-Blanco J, Garcia-Santos G (2010). Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway. J Pineal Res, 48, 72-80.
8. Claustrat B, Geoffriau M, Brun J (1995). Melatonin in humans: a biochemical marker of the circadian clock and an endogenous synchronizer. Neurophysiol Clin Sci, 2, 351-9.
9. Cohen EP, Robbins EC (2003). Radiation nephropathy. Seminars in Nephrology, 23, 486-99.
10. Cos S, Mediavilla MD, Fernandez R (2002). Melatonin induce apoptosis in MCF-7 human breast cancer cells in vitro. J Pineal Res, 32, 90-4.
11. Edwards JC, Chapman D, Cramp WA (1984). The effects of ionizing radiation on biomembrane structure and function. Prog Biophys Mol Biol, 43, 71-93.
12. Glatstein E, Fajanda LF, Brown JM (1977). Radiation injury in the mouse kidney-I sequential light microscopic study. Int J Radiat Oncol Biol Phys, 2, 933-43.
13. Hara M, Yoshida M, Nishijima H (2001). Melatonin: a pineal secretory product with antioxidant properties, protects against cisplatin-induced nephrotoxicity in rats. J Pineal Res, 30, 129-38.
14. Hedlund L, Lischko MM, Rollag MD (1976). Melatonin cycle in plasma and cerebrospinal fluid of calves. Science, 195, 686-7.
15. Jongejan HTM, Van Der Kogel AJ, Provoost AP (1987). Radiation Nephropathy in Young and Adult Rats. Int J Radiation Oncology Biol Phys, 13, 225-32.
16. Kennaway DJ, Voultsios A (1998). Circadian rhythm of free melatonin in human plasma. J Clin Endocrinol Metab, 83, 1013-5.
17. Kunkler PB, Farr RF, Luxton RW (1952). The limit of renal tolerance to X rays. Br J Radiol, 25, 190-201.
18. Luxton, Kunkler (1964). Radiation nephritis. Acta Radiol, 2, 169-78.
19. Madrazo AA, Churg J (1976). Radiation nephritis. Chronic changes following moderate doses of radiation. Lab Invest, 34, 283-90.
20. Majsterek I, Gloc E, Blasiak J (2005). A comparison of the action of amifostine and melatonin on DNA damaging effects and apoptosis induced by idarubicin in normal and cancer cells. J Pineal Res, 38, 254-63.
21. Manda K, Bhatia AL (2003). Melatonin-induced reduction in age-related accumulation of oxidative damage in mice. Biogerontology, 4, 133-9.
22. Martinez-Cayuela M (1955). Oxygen free radicals and human disease. Biochimie, 77, 147-61.
23. Nair CKK, Parida DK, Nomura T (2001). Radioprotectors in Radiotherapy. J Radiat Res, 42, 21-37.
24. Nowak R, McMillen JC, Redman J (1987). The correlation between serum and salivary melatonin concentrations and urinary 6-hydroxymelatonin sulphate excretion rates: Two non-invasive techniques for monitoring human circadian rhythmicity. Clin Endocrinol (Oxf), 27, 445-52.
25. Ong ACM, Fine LG (1994). Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis, 23, 205-9.
26. Pardridge WM, Meitus LJ (1980). Transport of albumin-bound melatonin through the blood-brain barrier. J Neurochem, 34, 1761-3.
27. Perez CA, Halperin EC (2008). Principles and Practice of Radiation Oncology, ed 5. Lippincott Williams and Wilkins; Philadelphia.
28. Reiter RJ (1986). Normal patterns of melatonin levels in the pineal gland and body fluids of humans and experimental animals. J Neural Transm, 21, 35-54.
29. Reiter RJ, Tan DX, Manchester LC (2001). Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: A review of the evidence. Cell Biochem Biophys, 34, 237-56.
30. Robbins MEC, Stephens LC, Thames HD (1994). Radiation response of the monkey kidney following controlateral nephrectomy. Int J Radiat Oncol Biol Phys, 30, 347-54.
31. Robbins MEC, Wooldridge MJA, Jaenke RS (1991). A morphological study of radiation nephropathy in the pig. Radiat Res, 126, 317-27.
32. Rodriguez C, Mayo JC, Sainz RM (2004). Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res, 36, 1-9.
33. Rodringuez-Garcia A, Mayo JC, Hevia D (2012). Phenotypic changes caused by melatonin increased sensitivity of prostate cancer cells to cytokine-induced apoptosis. J Pineal Res, 31.
34. Rousseau A, Petren S, Planntin J (1999). Serum and cerebrospinal fluid concentrations of melatonin: a pilot study in healthy male volunteers. J Neural Transm, 106, 883-8.
35. Russcher M, Koch B, Nagtegaal E (2012). The role of melatonin treatment in chronic kidney disease. Front Biosci, 17, 2644-56.
36. Shaw PF, Kennaway DJ, Seamark RF (1989). Evidence of high concentrations of melatonin in lateral ventricular cerebrospinal fluid of sheep. J Pineal Res, 6, 201-8.
37. Shirazi A, Ghobadi G, Ghazi-Khansari M (2007). A radiobiological review on melatonin: a novel radioprotector. J Radiat Res, 48, 263-72.
38. Snyder SH, Axelrod J (1967). Circadianrhythm in the serotonin content in the pineal gland: Regulating factors. J Pharmacol Exp Ther, 158, 206-13.
39. Stephens LC, Robbins MEC, Thames HD (1995). Radiation nephropathy in the rhesus monkey: morphometric analysis of glomerular and tubular alterations. Int J Radiat Oncol Biol Phys, 31, 865-73.
40. Tan DX, Manchester LC, Reiter J (1999). High physiological levels of melatonin in bile of mammals. Life Sci, 65, 523-9.
41. Vakkuri O (1985). Diurnal rhythm of melatonin in human saliva. Acta Physiol Scand, 124, 409-12.
42. Verma SP, Sonwalker N (1991). Structural changes in plasma membranes prepared from irradiated Chinese hamster V79 cells as revealed by raman spectroscopy. Radiat Res, 126, 27-35.
43. Vijayalaxmi ML, Reiter RJ, Herman TS (1999). Melatonin and Protection from Genetic Damage in Blood and Bone Marrow: Whole Body Irradiation Studies in Mice. J Pineal Res, 27, 221-5.
44. Vijayalaxmi ML, Reiter RJ, Sewerynek E (1995). Marked Reduction of Radiation İnduced Micronuclei in Human Blood Lymphocytes Pre-treated with Melatonin. Radiat Res, 143, 102-6.
45. Vijayalaxmi ML, Reiter RJ, Tan DX (2004). Melatonin as a radioprotective agent: a review. Int J Radiation Oncology Biol Phys, 59, 639-53.
46. Wang YM, Jin BZ, Ai F (2012). The efficacy and safety of melatonin in concurrent chemotherapy or radiotherapy for solid tumors: a meta-analysis of randomized controlled trials. Cancer Chemother Pharmacol, 69, 1213-20.
47. Zaki EL, Springate JE, Taub M (2003). Comparative toxicity of ifosfamide metabolites and protective effects of mesna and amifostine in cultured renal tubular cells. Toxicology in Vitro, 17, 397-402.
48. Zhang B, Su Y, Wang Y (2005). Involvement of Peroxiredoxin I in Protecting Cells from Radiation-Induced Death. J Radiation Res, 46, 305-12.